Friday, 31 August 2018

AstraZeneca lupus drug fails to meet main goal in study

AstraZeneca's experimental drug anifrolumab failed to meet its main target in a late-stage clinical study treating patients with moderate to severe lupus, the British drugmaker said on Friday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)